Catalyst

Slingshot members are tracking this event:

InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
NSPR

100%

Additional Information

Additional Relevant Details “Best efforts” public offering of approximately 442,424 shares of Series B Convertible Preferred Stock and accompanying warrants to purchase up to approximately 44,242,424 shares of common stock. Each share of Series B Convertible Preferred Stock is convertible into 100 shares of common stock at a conversion price equal to $0.33 per share, and the holders of Series B Convertible Preferred Stock will be entitled to receive cumulative dividends at the rate per share of 15% per annum of the stated value for five years. The warrants shall be exercisable immediately and have a term of exercise of five years from the date of issuance and have an exercise price of $0.20 per share of common stock. The Company expects to receive gross proceeds of approximately $14.6 million from the offering, before deducting placement agent fees and estimated offering expenses payable by the Company, assuming completion of the maximum offering.
http://www.inspiremd...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 30, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Public Ofering, Best Efforts, Series B Convertible Preferred Stock